Stericycle (SRCL)
(Delayed Data from NSDQ)
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
How Will Stericycle's (SRCL) Top Line Shape Up in Q3 Earnings?
by Zacks Equity Research
Stericycle's (SRCL) revenues in third-quarter 2018 are likely to decline on a year-over-year basis.
Stericycle (SRCL) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Hold Stericycle Stock In Your Portfolio?
by Zacks Equity Research
Strategic acquisitions and consistent efforts to develop internally aid Stericycle (SRCL) build robust customer base.
Stericycle (SRCL): Moving Average Crossover Alert
by Zacks Equity Research
Stericycle, Inc. (SRCL) could be a stock to avoid from a technical perspective
Stericycle (SRCL) Q2 Earnings Beat Estimates, '18 View Down
by Zacks Equity Research
Stericycle (SRCL) second-quarter 2018 earnings improve on a year-over-year basis but sales decline.
Stericycle (SRCL) Tops Q2 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 3.54% and -1.43%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
How Will Stericycle's (SRCL) Top Line Shape Up in Q2 Earnings?
by Zacks Equity Research
Stericycle's (SRCL) revenues in second-quarter 2018 are likely to decline on a year-over-year basis.
Aptiv (APTV) to Report Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Aptiv's (APTV) technology investments, acquisitions and collaborations should help it capitalize on developing automotive markets.
Revenue Growth & Tax Benefit to Drive ADP's Q4 Earnings
by Zacks Equity Research
Lower tax rate, acquisitions, solid segmental performance, improving operating performance and favorable foreign currency movements are likely to boost ADP's fourth-quarter fiscal 2018 results.
Fiserv (FISV) Q2 Earnings: Will Higher Revenues, Tax Cut Aid?
by Zacks Equity Research
Fiserv's (FISV) second-quarter 2018 results are likely to benefit from lower tax rates, higher internal revenue growth and strong performance across majority of its segments.
Here's Why Investors Should Hold Stericycle (SRCL) Stock Now
by Zacks Equity Research
Stericycle (SRCL) looks promising on the back of its strategic acquisitions in both domestic and international markets.
Monthly Job Additions Remain Sturdy: 4 Stocks Worth Buying
by Shuvra Shankar Dey
With the biggest recruiter of the month being professional and business services, adding stocks from this sector looks like a smart choice.
Here's Why a Hold Strategy Is Apt for Verisk (VRSK) Stock Now
by Zacks Equity Research
Verisk's (VRSK) solid organic growth, strategic acquisitions and technology utilizations bode well for the company.
CRA International Rides on Diversification, Talent Costs Hurt
by Zacks Equity Research
CRA International (CRAI) continues to grow with the help of its global network, diversified business model and excellent professional team. However, higher talent costs remains a concern.
Clean Harbors (CLH) Rides on Buyouts, High Debt a Concern
by Zacks Equity Research
Clean Harbors (CLH) continues to grow with the help of multiple acquisitions in both new and existing markets. However, a debt-laden balance sheet is concern.
Stericycle (SRCL) Rides on Client Retention and Buyouts
by Zacks Equity Research
Stericycle's (SRCL) acquisition pool remains robust in multiple geographies and lines of business.
RSG or SRCL: Which Waste Removal Stock is Better Placed?
by Zacks Equity Research
Republic Services (RSG) seems to have an edge over Stericycle (SRCL) with respect to most of the parameters considered.
Stericycle (SRCL) Up 7.5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Stericycle (SRCL) reported earnings 30 days ago. What's next for the stocl? We take a look at earnings estimates for some clues.
Here's Why Investors Should Retain Stericycle (SRCL) Stock
by Zacks Equity Research
Stericycle's (SRCL) acquisition pool remains robust in multiple geographies and lines of business.
WM or SRCL: Which Waste Removal Stock is Better Placed?
by Zacks Equity Research
While Waste Management (WM) is performing well on the bourse and has a higher expected earnings growth, Stericycle (SRCL) has an edge in terms of earnings estimate revisions and valuation.
Stericycle (SRCL) Beats on Q1 Earnings, Ups '18 Revenue View
by Zacks Equity Research
Stericycle's first-quarter 2018 results benefit from strong business performance and U.S. tax reform.
Stericycle (SRCL) Q1 Earnings: Is Disappointment in Store?
by Zacks Equity Research
Lower organic revenue growth, unfavorable impact of divestures, non-cash goodwill impairment charges and expenses related to business transformation are likely to hurt Stericycle's (SRCL) Q1 results.
Stericycle (SRCL) Down 17.7% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Stericycle (SRCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stericycle (SRCL) Q4 Earnings Miss on High Operating Costs
by Zacks Equity Research
Lower revenues and higher operating costs hurt Stericycle's (SRCL) fourth-quarter 2017 earnings.
Low Waste Revenues Might Mar Stericycle (SRCL) Q4 Earnings
by Zacks Equity Research
Stiff competition and government rules and regulations are likely to hurt Stericycle's (SRCL) bottom line in Q4.